Genocea Biosciences Inc (NASDAQ:GNCA) Stock Slumps After Initial Data from GEN-011 Phase 1/2a Trial

April 13, 2022

Biopharmaceutical company Genocea Biosciences Inc (NASDAQ:GNCA) has seen its stock decline sharply in recent days and the situation remained the same yesterday as it declined by another 18% amidst a heavy selloff. The decline in the Genocea over the past week stretched to a staggering 65% following yesterday’s fall. Trading Data On Tuesday, GNCA stock went down 18.33% to $0.49 with more than 5.17 million shares, compared to its average…

Read More >>

Wednesday’s Microcap Momentum List: WHSI, HOTH, ATHX, CYTO, GNCA, KTRA

Following were the notable penny stock buzzers in the previous session on high volume. Keep an eye on these stocks this week. If you are interested in nanocap stocks here is one you should look into Wearable Health Solutions (OTCMKTS:WHSI)  is a manufacturer of next-generation, advanced technology personal medical alarms and safety alert devices.  WHSI’s technology can provide a leading edge for the Company in our current cutting-edge technology-driven markets….

April 13, 2022
Read More >>